Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung carcinomas decrease the number of monocytes/macrophages (CD14+ cells) that produce TNF-alpha.

Jose Sullivan Lopez-Gonzalez1, Federico Avila-Moreno, Heriberto Prado-Garcia

  • 1Departamento de Enfermedades Cronico-Degenerativas, Instituto Nacional de Enfermedades Respiratorias, Mexico, DF. slopezgonzalez@yahoo.com

Clinical Immunology (Orlando, Fla.)
|December 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytokine and profibrotic gene expression during tracheal stenosis development in an experimental model.

Scientific reports·2026
Same author

Drug-tolerant persister cells in cancer: a scoping review of definitions, models, and molecular mechanisms.

Frontiers in oncology·2026
Same author

The tumor microenvironment: adding pieces to the puzzle.

Frontiers in immunology·2026
Same author

Glyoxalase-1 Inhibition Leads to Ferroptosis Induction in Lung Cancer Cells: A Dual Mechanism of Action of Hydroxamic Acids Derived from Cysteine.

ChemMedChem·2025
Same author

Cascade Testing Among Patients With Breast Cancer: Current Situation and Challenges in Latin America.

JCO global oncology·2025
Same author

Increased Antiproliferative Activity of Antiestrogens and Neratinib Treatment by Calcitriol in HER2-Positive Breast Cancer Cells.

International journal of molecular sciences·2025
Same journal

A novel JAK1 mutation identified in a patient with severe atopic dermatitis phenotype: Mechanistic insights and IL-4Rα targeted therapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

VNN1 aggravates sepsis by promoting inflammation and oxidative stress through PPARγ signaling VNN1 in sepsis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Comparison between glioblastoma and brain metastases: How epigenetic remodeling can enhance immunotherapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

JAK-STAT3-MYC axis defines pathogenic stem cell-like memory CD4<sup>+</sup> T cells in rheumatoid arthritis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

The baseline vaginal immune milieu is an important determinant of the inflammatory response induced by penile-vaginal sex.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Adulthood diagnosis of Nijmegen breakage syndrome in twins with antibody deficiency clinical presentation.

Clinical immunology (Orlando, Fla.)·2026
See all related articles

Lung cancer patients show reduced tumor necrosis factor-alpha (TNF-alpha)-producing monocytes compared to healthy donors. This suggests lung carcinomas may suppress immune responses by altering macrophage phenotypes, potentially aiding tumor growth.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Inflammation's role in cancer development is complex and not fully understood.
  • Tumor necrosis factor-alpha (TNF-alpha) is a key inflammatory cytokine implicated in various diseases, including cancer.
  • Monocytes (CD14+ cells) are crucial immune cells involved in inflammatory and anti-tumor responses.

Purpose of the Study:

  • To investigate the levels of TNF-alpha-producing monocytes in lung cancer patients compared to tuberculosis patients and healthy individuals.
  • To explore the impact of lung carcinoma on TNF-alpha production by macrophages.
  • To elucidate the potential mechanisms by which lung cancer influences macrophage function and TNF-alpha expression.

Main Methods:

  • Comparative analysis of TNF-alpha-producing CD14+ cells in peripheral blood and pleural effusion samples.

Related Experiment Videos

  • Utilized an experimental model to study cellular alterations in TNF-alpha production.
  • Assessed TNF-alpha transcript expression levels in macrophages.

    • Main Results:

    • Significantly lower TNF-alpha-producing CD14+ cells were observed in the peripheral blood of lung cancer patients compared to healthy donors.
    • Pleural effusion analysis revealed significantly fewer TNF-alpha-producing CD14+ cells in lung cancer patients than in tuberculous patients.
    • Experimental models suggested reduced TNF-alpha transcript expression contributes to decreased TNF-alpha production.

    Conclusions:

    • Lung carcinomas appear to suppress TNF-alpha production by macrophages.
    • This suppression may involve the induction of an M2 macrophage phenotype, which is known to promote tumor progression.
    • These findings highlight a novel mechanism by which lung cancer may evade immune surveillance and foster tumor growth.